ETC
BNTX icon

Exchange Traded Concepts’s BioNTech BNTX Stock Holding History

Exchange Traded Concepts’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,263
Closed -$115K – 1417
2025
Q1 		$115K Sell
1,263
-93
-7% -$10.4K ﹤0.01% 1108
2024
Q4 		$155K Hold
1,356
– – ﹤0.01% 1050
2024
Q3 		$161K Sell
1,356
-984
-42% -$90.5K ﹤0.01% 1035
2024
Q2 		$188K Sell
2,340
-727
-24% -$66.5K ﹤0.01% 883
2024
Q1 		$283K Buy
3,067
+1,827
+147% +$175K 0.01% 829
2023
Q4 		$131K Buy
1,240
+314
+34% +$31.6K ﹤0.01% 851
2023
Q3 		$101K Sell
926
-304
-25% -$33.6K ﹤0.01% 893
2023
Q2 		$133K Buy
+1,230
New +$138K ﹤0.01% 881

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Exchange Traded Concepts's BNTX Position: Q2 2025 in Review

Exchange Traded Concepts sold out of BioNTech (BNTX) in Q2 2025, closing a stake of 1,263 shares — an estimated $115K sold.

Exchange Traded Concepts first reported a position in BNTX in Q2 2023 and held it in 8 quarters. The position peaked at $283K in Q1 2024. 258 funds tracked by Wall St. Rank hold BNTX as of Q2 2025.

  • Exchange Traded Concepts reported no remaining BioNTech position as of Q2 2025 after selling out during the quarter.
  • Exchange Traded Concepts sold 1,263 BioNTech shares in Q2 2025, an estimated $115K.
  • Exchange Traded Concepts first reported a position in BioNTech in Q2 2023 and held it in 8 quarters.
  • Exchange Traded Concepts's BioNTech position peaked at $283K in Q1 2024.
  • 258 funds tracked by Wall St. Rank held BioNTech as of Q2 2025.

Based on Exchange Traded Concepts's 13F filing for Q2 2025, filed 10 Jul 2025.